 |
|
Brain's cannabinoid system 'mellows' seizures
August 17, 2006The same brain machinery that responds to the active substance in marijuana provides a central "on-demand" protection against seizures, researchers have found. They said their discoveries suggest that the "endocannabinoid" system might constitute a prime target for drugs against seizures of epilepsy and other neurodegenerative diseases.
The findings were published by Beat Lutz and Giovanni Marsicano, of Max Planck Institute of Psychiatry and Johannes Gutenberg University in Mainz, and colleagues in the August 17, 2006, issue of the journal Neuron, published by Cell Press.
Thus, Lutz, Marsicano, and his colleagues used genetic techniques to pinpoint the role of the endocannabinoid system on these neurons and on seizure activity. They used mice as their animal model and induced seizures in these mice with the chemical kainic acid (KA).
In particular, they wanted to explore the role played by the endocannabinoid system in hippocampal neurons that are responsive to the neurotransmitter glutamine. These neurons are known to play a central role in seizure activity. The endocannabinoid regulatory system is also active in another type of neuron triggered by the neurotransmitter gamma-aminobutyric acid (GABA).
Thus, the researchers conducted experiments in which they genetically knocked out the endocannabinoid receptor CB1 and analyzed the effects on seizure sensitivity. They found that, indeed, when they knocked out CB1 in glutamatergic, but not GABAergic neurons, the chemically induced seizures increased in the mice. In fact, their experiments all but ruled out the role of GABAergic neurons in the seizure-protection function, they concluded.
"Altogether, these results confirm that physiological endocannabinoid-dependent control of GABAergic transmission depends on intact CB1 signaling in GABAergic interneurons and suggest that the endocannabinoid system does not influence GABAergic transmission during the development of KA-induced seizures," they concluded. "Therefore, direct modulation of glutamatergic transmission by CB1 receptors expressed on cortical glutamatergic neurons appears to be the major mechanism of endocannabinoid-mediated protection against KA-induced seizures."
Furthermore, the researchers' experiments established that endocannabinoid receptors were also present in the same glutamatergic neurons in areas of the hippocampus known to be central to seizure generation. The researchers wrote that this finding "represents a novel step in understanding the progression of acute excitotoxic seizures and the development of epileptic states."
And significantly, when the researchers used a targeted virus to knock out the CB1 gene for the endocannabinoid receptor specifically in the glutamatergic neurons of the hippocampus, the mice also showed strong worsening of chemically induced seizures in comparison to mice still expressing CB1.
"Altogether, these observations support a hypothetical scenario in which acute KA-induced excitotoxic seizures would activate the endocannabinoid system in respect to its ability to inhibit only 'harmful' glutamatergic transmission, but not 'protective' GABAergic release," concluded Lutz, Marsicano, and colleagues.
"In conclusion, our study reveals a mechanism through which the endocannabinoid system is able to provide on-demand protection against acute behavioral seizures. CB1 expression on hippocampal glutamatergic circuits accounts for this protection and might represent a suitable target for the treatment of neurological disorders associated with excessive neuronal excitation," they wrote.
Cell Press
Endocannabinoid Current Events and Endocannabinoid News RSSStrong link between obesity and depression
Doctors should pay more attention to the link between common mental illness and obesity in patients because the two health problems are closely linked, according to researchers at the University of Adelaide.
Active ingredients in marijuana found to spread and prolong pain
Imagine that you're working on your back porch, hammering in a nail. Suddenly you slip and hit your thumb instead - hard. The pain is incredibly intense, but it only lasts a moment. After a few seconds (and a few unprintable words) you're ready to start hammering again.
Scripps research team defines new painkilling chemical pathway
Marijuana kills pain by activating a set of proteins known as cannabinoid receptors, which can also regulate appetite, inflammation, and memory.
New brain cells implicated in machinery of cannabinoid signaling
The brain cells called astrocytes, and not just neurons, are sensitive to the substances called cannabinoids-the active chemicals in marijuana.
Leicester medical team announces 'predictor' for pregnant women who may have miscarriages
A medical team from the University of Leicester has been able to establish for the first time a predictor for pregnant women who may have miscarriages and those who won't. Their research is published in the highly prestigious Journal of the American Medical Association.
Curing addiction with cannabis medicines
Smokers trying to quit in the future could do it with the help of cannabis based medicines, according to research from The University of Nottingham.
Marijuana-like brain chemicals work as antidepressant
American and Italian researchers have found that boosting the amounts of a marijuana-like brain transmitter called anandamide produces antidepressant effects in test rats.
The endocannabinoids: Functional roles and therapeutic opportunities
Cannabis (marijuana) is the most widely produced plant-based illicit drug worldwide and the illegal drug most frequently used in Europe. Its use increased in almost all EU countries during the 1990s, in particular among young people, including school students.
Role seen for cannabis in helping to alleviate allergic skin disease
Administering a substance found in the cannabis plant can help the body's natural protective system alleviate an allergic skin disease (allergic contact dermatitis), an international group of researchers from Germany, Israel, Italy, Switzerland and the U.S. has found.
Discovery of novel nerve cell modulator offers potential for mood disorders, epilepsy treatments
The discovery of a novel molecular switch that powerfully modulates nerve cell activity offers the potential for new mood disorder and epilepsy treatments, University of California, Irvine researchers report.
More Endocannabinoid Current Events and Endocannabinoid News Articles
 |
Behavioral Neurobiology of the Endocannabinoid System (Current Topics in Behavioral Neurosciences) by Dave Kendall (Editor), Stephen Alexander (Editor) The endocannabinoid signaling system is one of the key modulators of central nervous function. This volume provides timely and in-depth coverage of the roles of the endocannabinoid signaling system in the neurobiology of behavior. It is essential reading for any researcher with a background in neuroscience wanting to know more about the endocannabinoids. |
 |
Abdominal Obesity and the Endocannabinoid System: From Basic Aspects to Clinical Management of Related Cardiometabolic Risk by Jean-Pierre Despres (Editor), Vincenzo Di Marzo (Editor) This internationally renowned author team provides a unique and thorough analysis and distillation of the endocannabinoid system and its relationship to abdominal obesity, diabetes, and cardiovascular disease. The endocannabinoid system (ECS) plays an important role in cardiometabolic risk, as well as modulating energy balance, feeding behavior, hepatic lipogenesis, and perhaps glucose homeostasis. Evidence suggests that the ECS is overactive in human obesity and dyslipidemia. Critical to the management of cardiometabolic risk, this new, timely book provides practical overviews and management guidance on many important topics, including:
|
|
Rimonabant cuts rate of metabolic syndrome by 53%: selective endocannabinoid type 1 receptor blocker improves weight loss, lipid profile.(News)(selective ... An article from: Internal Medicine News by Bruce Jancin (Author) This digital document is an article from Internal Medicine News, published by International Medical News Group on October 1, 2004. The length of the article is 1489 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Rimonabant cuts rate of metabolic syndrome by 53%: selective endocannabinoid type 1 receptor blocker improves weight loss, lipid profile.(News)(selective endocannabinoid type 1 receptor blockers) Author: Bruce Jancin Publication: Internal Medicine News (Magazine/Journal) Date: October 1, 2004 Publisher: International Medical News Group Volume: 37 Issue:... | |
 |
The Endocannabinoid System by Heike Gloede (Author) Two cannabinoid receptors and the enzymes, involved in the inactivation of endocannabinoids like anandamide and 2-arachidonoylglycerol, fatty acid amide hydrolase and cyclooxygenase-2 constitute the endocannabinoid system. The vanilloid receptor is also involved in endocannabinoid signaling, since it is also activated by endocannabinoids. It has been proposed that the endocannabinoid system plays an immunomodulatory role in gastrointestinal inflammatory disorders. Quantitative measurement of gene expression can be of interest for a better understanding of the role of the endocannabinoid system in inflammatory processes in the human gut. In this thesis several studies were performed where gene expression in human tissues or cell lines was measured. Further studies with human... |
 |
Endocannabinoids: The Brain and Body's Marijuana and Beyond by Emmanuel S Onaivi (Editor), Takayuki Sugiura (Editor), Vincenzo Di Marzo (Editor) Over the past decade, there have been major advances in understanding the mechanisms whereby marijuana interacts with the brain in producing psychoactive and potentially therapeutic effects. The discovery of specific gene coding for cannabinoid receptors activated by smoking marijuana, and the finding of endogenous cannabinoids, which also activate the receptors, have transformed cannabinoid research into mainstream science with significant implications in human health and disease Endocannabinoids: The Brain and Body’s Marijuana and Beyond documentsadvances in the discovery and functioning of naturally occurring marijuana-like substances in human biology. It explores recent findings that point to the existence of an endocannabinoid physiological control system (EPCS) that... |
 |
Cannabinoids and the Brain by Attila Köfalvi (Author), Attila Köfalvi (Editor) Endocannabinoids control most of the body functions, and in the brain, they modulate neurotransmission, synaptic plasticity, confer neuroprotection, control metabolism, neuro- and neuritogenesis, survival, cognitive and motor functions as well as a plethora of other higher-order brain functions. Their fruitful therapeutic potential is recognized by cannabinoid researchers and pharmaceutical companies, respectively. The aim of this book is to help clinicians, neuroscientists, as well as students, understand the significance of the endocannabinoid system. This book, however, also will be very useful to those who already feel comfortable with the neuroscience of endocannabinoids. The book will introduce the reader to the up-to-date neurobiology of endocannabinoids and related... |
 |
The Cannabinoid Receptors (The Receptors) by Patricia H. Reggio (Editor) As research has progressed, the cannabinoid CB 1 and CB 2 receptors have expanded significantly in importance within the neuroscience mainstream. In The Cannabinoid Receptors, leading experts introduce newcomers to the cannabinoid field with chapters covering cannabinoid ligand synthesis and structure activity relationships, the molecular pharmacology of the cannabinoid receptors and the endocannabinoid system, and ultimately, the whole animal pharmacology and therapeutic applications for cannabinoid drugs. Adding to those key topics, the book also examines the current direction of the field with chapters on new putative cannabinoid receptors and challenges for future research. As a part of The Receptors ™ series, this volume highlights its receptor with the most thorough, focused... |
 |
Reviews of Physiology, Biochemistry and Pharmacology / Volume 160 (Reviews of Physiology, Biochemistry and Pharmacology) by S. G. Amara (Author), S. G. Amara (Editor), E. Bamberg (Editor), B. Fleischmann (Editor), T. Gudermann (Editor), S. C. Hebert (Editor) Reviews of Physiology, Biochemistry and Pharmacology Volume 160 2008 V. di Marzo: Endocannabinoids: Synthesis and Degradation R. Rivera and J. Chun: Biological Effects of Lysophospholipids S. J. O Meara, K. Rodgers, and C. Godson: Lipoxins: Update and Impact of Endogenous Pro-Resolution Lipid Mediators R.K.P. Benninger, M. Hao, and D. Piston: Multi-photon Excitation Imaging of Dynamic Processes in Living Cells and Tissues G. Schmitz and M. Grandl: Lipid Homeostasis in Macrophages Implications for Atherosclerosis |
 |
Cannabinoids (Handbook of Experimental Pharmacology) (Volume 168) by Roger G. Pertwee (Editor) The present book is an outstanding summary of many aspects of cannabinoid research. It provides current knowledge about the pharmacology and therapeutic potential of cannabinoids as well as knowledge about the pharmacology, physiology, and pathology of the endogenous cannabinoid systems. The chapters are written by scientists who have made or are still making major contributions to the field. This book may well help generate novel ideas on how to approach the study of emotions. |
|
ENDOCANNABINOIDS by Takayuki Sugiura (Author) |
| © 2009 BrightSurf.com |